Professor Richard Sullivan Academics Affiliates Supervisors Director, Institute of Cancer Policy and Co-Director of the Centre for Conflict & Health Research Research subject areas Cancer Contact details richard.sullivan@kcl.ac.uk +44 (0) 77 2039 8401 @SullivanProf
Breast Cancer in Women in Gaza: A Review of Clinical Characteristics and Short-Term Survival Palliative Care in Turkey: Insights from Experts through Key Informant Interviews Global colorectal cancer research, 2007-2021: Outputs and funding National Palliative Care Strategy in a Conflict Affected Country: A Jordanian Demonstration Project Providing person-centered palliative care in conflict-affected populations in the Middle East: What matters to patients with advanced cancer and families including refugees? Redefining cancer research priorities in low- and middle-income countries in the post-COVID-19 global context: a modified Delphi consensus process Revitalising cancer trials post-pandemic: time for reform Stress, resilience, and moral distress among health care providers in oncology during the COVID-19 pandemic The challenges of international collaboration in conflict and health research: experience from the Research for Health in Conflict-Middle East and North Africa (R4HC-MENA) partnership Toward an integrated approach for mental health and psychosocial support and peacebuilding in North-East Nigeria: programme description and preliminary outcomes from ‘Counselling on Wheels’ Adaptation of Intercultural Sensitivity Scale for Turkish medical students Are patients with cancer at higher risk of COVID-19-related death? A systematic review and critical appraisal of the early evidence Cancer among syrian refugees living in Konya Province, Turkey Cancer in sub-Saharan Africa: a Lancet Oncology Commission Cancer Medicines: What Is Essential and Affordable in India? Cancer medicines on the WHO Model List of Essential Medicines: processes, challenges, and a way forward Cancer research across Africa: a comparative bibliometric analysis Cancer research collaboration between the UK and the USA: reflections on the 2021 G20 Summit announcement Conflict in Ukraine undermines an already challenged health system COVID-19 and Cancer Global Modelling Consortium (CCGMC): A global reference to inform national recovery strategies COVID-19 vaccination in patients with cancer, a rapid review Defining Essential Childhood Cancer Medicines to Inform Prioritization and Access: Results From an International, Cross-Sectional Survey Editorial: The effects of COVID-19 on cancer research methods & strategies Health service planning to assess the expected impact of centralising specialist cancer services on travel times, equity, and outcomes: a national population-based modelling study How Should Access to Military Health Care Facilities Be Controlled in Conflict? Industry Funding of Oncology Randomised Controlled Trials: Implications for Design, Results and Interpretation Informal Providers—Ground Realities in South Asian Association for Regional Cooperation Nations: Toward Better Cancer Primary Care: A Narrative Review Is Clinical Research Serving the Needs of the Global Cancer Burden? An Analysis of Contemporary Global Radiation Therapy Randomized Controlled Trials Palliative Care in 2020 & Beyond Workshop: an expert symposium to develop palliative care advocacy in Turkey Participation of Lower and Upper Middle-Income Countries in Clinical Trials Led by High-Income Countries Primary care and cancer: an analysis of the impact and inequalities of the COVID-19 pandemic on patient pathways Priorities for cancer research in low- and middle-income countries: a global perspective Prioritising locations for radiotherapy equipment in Brazil: a cross-sectional, population-based study and development of a LINAC shortage index Radiotherapy in conflict: lessons from Ukraine Randomized Controlled Trials in Lung, Gastrointestinal, and Breast Cancers: An Overview of Global Research Activity Spend less to achieve more: Economic analysis of intermittent versus continuous cetuximab in KRAS wild-type patients with metastatic colorectal cancer System-Level Capacity of High-Dose Rate (HDR) Brachytherapy for Management of Cervical Cancer in an Upper-Middle Income Country: A Case Study From Brazil The health of internally displaced people in Syria: are current systems fit for purpose? The risk of contracting SARS-CoV-2 or developing COVID-19 for people with cancer: A systematic review of the early evidence Trends in drug revenue among major pharmaceutical companies: A 2010-2019 cohort study What Really Matters for Cancer Care – Health Systems Strengthening or Technological Innovation? Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey An Analysis of Contemporary Oncology Randomized Clinical Trials from Low/Middle-Income vs High-Income Countries Association between COVID-19 burden and delays to diagnosis and treatment of cancer patients in England Better to light a flamethrower, than curse the darkness Biomedicine and the soul of medicine: optimising the balance Building Resilient Health Systems Intelligence: Adapting Indicators of Compromise for the Cyber-Bionexus Cancer and COVID-19 vaccines: a complex global picture Cancer Biomarkers in the era of precision oncology: Addressing the needs of patients and health systems Cancer in the older Indian population: Understanding the current context in an emerging economy View all publications
12 November 2024 COMMENT: What a Trump presidency means for global health Global health is likely to be radically altered with Donald Trump in the White House. For starters,…